Data Mining of the US FDA’s Adverse Events Reporting System Database to Evaluate Drug–Drug Interactions Associated with Statin-Induced Rhabdomyolysis-Reference-Cited by-同舟云学术

Data Mining of the US FDA’s Adverse Events Reporting System Database to Evaluate Drug–Drug Interactions Associated with Statin-Induced Rhabdomyolysis

Published:2016-10-05 Issue:6 Volume:30 Page:327-337
ISSN:1178-2595
Container-title:Pharmaceutical Medicine
language:en
Short-container-title:Pharm Med

Author:

Muñoz Monica A.,Tonning Joseph M.,Brinker Allen D.,Delaney Joseph A. C.,Gatti Jasmine C.,Avigan Mark

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology

Link

http://link.springer.com/content/pdf/10.1007/s40290-016-0162-6.pdf

Reference40 articles.

1. Fleg JL, Aronow WS, Frishman WH. Cardiovascular drug therapy in the elderly: benefits and challenges. Nat Rev Cardiol. 2011;8(1):13–28. doi: 10.1038/nrcardio.2010.162 .

2. Budnitz DS, Lovegrove MC, Shehab N, Richards CL. Emergency hospitalizations for adverse drug events in older Americans. N Engl J Med. 2011;365(21):2002–12. doi: 10.1056/NEJMsa1103053 .

3. Pilotto A, Panza F, Seripa D. Pharmacogenetics in geriatric medicine: challenges and opportunities for clinical practice. Curr Drug Metab. 2011;12(7):621–34.

4. Gu Q, Paulose-Ram R, Burt VL, Kit BK. Prescription cholesterol-lowering medication use in adults aged 40 and over: United States, 2003–2012. NCHS data brief, no. 177. National Center for Health Statistics; 2014. http://www.cdc.gov/nchs/data/databriefs/db177.pdf . Accessed 22 Sep 2016.

5. Bugeja G, Kumar A, Banerjee AK. Exclusion of elderly people from clinical research: a descriptive study of published reports. BMJ. 1997;315(7115):1059.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Statistical Methodologies for Detecting Drug-Drug Interaction Using Spontaneous Reporting System;Journal of Health Informatics and Statistics;2024-02-28

2. Application of an Integrative Drug Safety Model for Detection of Adverse Drug Events Associated With Inhibition of Glutathione Peroxidase 1 in Chronic Obstructive Pulmonary Disease;Pharmaceutical Research;2023-05-12

3. A Standardized Dataset of a Spontaneous Adverse Event Reporting System;Healthcare;2022-02-23

4. Rhabdomyolysis risk from the use of two‐drug combination of antidyslipidemic drugs with antihypertensive and antidiabetic medications: a signal detection analysis;Fundamental & Clinical Pharmacology;2018-12-21